Literature DB >> 17420426

Variation in nursing home antipsychotic prescribing rates.

Paula A Rochon1, Therese A Stukel, Susan E Bronskill, Tara Gomes, Kathy Sykora, Walter P Wodchis, Michael Hillmer, Alexander Kopp, Jerry H Gurwitz, Geoffrey M Anderson.   

Abstract

BACKGROUND: Excessive prescribing of antipsychotic therapy is a concern owing to their potential to cause serious adverse events. We explored variation in the use of antipsychotic therapy across nursing homes in Ontario, Canada, and determined if prescribing decisions were based on clinical indications.
METHODS: A point-prevalence study of antipsychotic therapy use in 47 322 residents of 485 provincially regulated nursing homes in December 2003. Facilities were classified into quintiles according to their mean antipsychotic prescribing rates. Residents were grouped into those with a potential clinical indication or no identified clinical indication for antipsychotic therapy.
RESULTS: A total of 15 317 residents (32.4%) were dispensed an antipsychotic agent. The mean rate of antipsychotic prescribing by home ranged from 20.9% in the quintile of facilities with the lowest mean prescribing rates (quintile 1) to 44.3% in facilities with the highest mean prescribing rates (quintile 5). Compared with individuals residing in nursing homes with the lowest mean antipsychotic prescribing rates, those residing in facilities with the highest rates were 3 times more likely to be dispensed an antipsychotic agent (adjusted odds ratio [AOR], 3.0; 95% confidence interval [CI], 2.74-3.19). Similar rates were observed among residents with psychoses with or without dementia (AOR, 2.7; 95% CI, 2.35-3.09) and residents without psychoses or dementia (AOR, 2.9; 95% CI, 2.19-3.81) who had no identifiable indication for an antipsychotic therapy.
CONCLUSION: Residents in facilities with high antipsychotic prescribing rates were about 3 times more likely than those in facilities with low prescribing rates to be dispensed an antipsychotic agent, irrespective of their clinical indication.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17420426     DOI: 10.1001/archinte.167.7.676

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  47 in total

1.  Comparison of different approaches to confounding adjustment in a study on the association of antipsychotic medication with mortality in older nursing home patients.

Authors:  Krista F Huybrechts; M Alan Brookhart; Kenneth J Rothman; Rebecca A Silliman; Tobias Gerhard; Stephen Crystal; Sebastian Schneeweiss
Journal:  Am J Epidemiol       Date:  2011-09-20       Impact factor: 4.897

Review 2.  Challenge of changing nursing home prescribing culture.

Authors:  Jennifer Tjia; Jerry H Gurwitz; Becky A Briesacher
Journal:  Am J Geriatr Pharmacother       Date:  2012-01-20

3.  Development of pharmaceutical care services in nursing homes: practice and research in a Swiss canton.

Authors:  Jean-François Locca; Martine Ruggli; Michel Buchmann; Jacques Huguenin; Olivier Bugnon
Journal:  Pharm World Sci       Date:  2008-12-06

4.  Use of antipsychotics among elderly nursing home residents with dementia in the US: an analysis of National Survey Data.

Authors:  Pravin Kamble; Hua Chen; Jeffrey T Sherer; Rajender R Aparasu
Journal:  Drugs Aging       Date:  2009       Impact factor: 3.923

5.  Influences on the start, selection and duration of treatment with antibiotics in long-term care facilities.

Authors:  Nick Daneman; Michael A Campitelli; Vasily Giannakeas; Andrew M Morris; Chaim M Bell; Colleen J Maxwell; Lianne Jeffs; Peter C Austin; Susan E Bronskill
Journal:  CMAJ       Date:  2017-06-26       Impact factor: 8.262

Review 6.  Withholding, discontinuing and withdrawing medications in dementia patients at the end of life: a neglected problem in the disadvantaged dying?

Authors:  Carole Parsons; Carmel M Hughes; A Peter Passmore; Kate L Lapane
Journal:  Drugs Aging       Date:  2010-06-01       Impact factor: 3.923

7.  Trends in the use and cost of antipsychotics among older adults from 2007 to 2013: a repeated cross-sectional study.

Authors:  Paul D Foster; Ximena Camacho; Simone Vigod; Zhan Yao; David N Juurlink; J Michael Paterson; Muhammad M Mamdani; Diana Martins; Tara Gomes
Journal:  CMAJ Open       Date:  2016-06-10

8.  Documentation of antipsychotic use and indications for newly diagnosed, nonaggressive dementia patients.

Authors:  Nikhil Dhawan; Avila B Steele; Robert O Morgan; A Lynn Snow; Jessica A Davila; Mark E Kunik
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2008

9.  All-cause mortality associated with atypical and conventional antipsychotics among nursing home residents with dementia: a retrospective cohort study.

Authors:  Rosa Liperoti; Graziano Onder; Francesco Landi; Kate L Lapane; Vincent Mor; Roberto Bernabei; Giovanni Gambassi
Journal:  J Clin Psychiatry       Date:  2009-10       Impact factor: 4.384

10.  Antipsychotic medication utilization in nonpsychiatric hospitalizations.

Authors:  Shoshana J Herzig; Michael B Rothberg; Jamey R Guess; Jerry H Gurwitz; Edward R Marcantonio
Journal:  J Hosp Med       Date:  2016-04-30       Impact factor: 2.960

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.